161 related articles for article (PubMed ID: 18855598)
1. Design and evaluation of chitosan films for transdermal delivery of glimepiride.
Ammar HO; Salama HA; El-Nahhas SA; Elmotasem H
Curr Drug Deliv; 2008 Oct; 5(4):290-8. PubMed ID: 18855598
[TBL] [Abstract][Full Text] [Related]
2. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
[TBL] [Abstract][Full Text] [Related]
3. A transdermal delivery system for glipizide.
Ammar HO; Salama HA; Ghorab M; El-Nahhas SA; Elmotasem H
Curr Drug Deliv; 2006 Jul; 3(3):333-41. PubMed ID: 16848735
[TBL] [Abstract][Full Text] [Related]
4. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
[TBL] [Abstract][Full Text] [Related]
5. Optimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patches.
Ahmed OA; Afouna MI; El-Say KM; Abdel-Naim AB; Khedr A; Banjar ZM
Expert Opin Drug Deliv; 2014 Jul; 11(7):1005-13. PubMed ID: 24702435
[TBL] [Abstract][Full Text] [Related]
6. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride.
Akram MR; Ahmad M; Abrar A; Sarfraz RM; Mahmood A
Drug Des Devel Ther; 2018; 12():349-364. PubMed ID: 29503528
[TBL] [Abstract][Full Text] [Related]
7. Effect of pH and complexation on transdermal permeation of gliquidone.
Sridevi S; Diwan PV
Pharmazie; 2002 Sep; 57(9):632-4. PubMed ID: 12369452
[TBL] [Abstract][Full Text] [Related]
8. Quality by design coupled with near infrared in formulation of transdermal glimepiride liposomal films.
Ahmed OAA; Kurakula M; Banjar ZM; Afouna MI; Zidan AS
J Pharm Sci; 2015 Jun; 104(6):2062-2075. PubMed ID: 25873019
[TBL] [Abstract][Full Text] [Related]
9. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Aug; 320(1-2):53-7. PubMed ID: 16701974
[TBL] [Abstract][Full Text] [Related]
10. Design of antihistaminic transdermal films based on alginate-chitosan polyelectrolyte complexes: characterization and permeation studies.
Lefnaoui S; Moulai-Mostefa N; Yahoum MM; Gasmi SN
Drug Dev Ind Pharm; 2018 Mar; 44(3):432-443. PubMed ID: 29098871
[TBL] [Abstract][Full Text] [Related]
11. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of glimepiride: development and antidiabetic activity in albino rabbits.
Mohd AB; Sanka K; Bandi S; Diwan PV; Shastri N
Drug Deliv; 2015; 22(4):499-508. PubMed ID: 24471856
[TBL] [Abstract][Full Text] [Related]
12. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
Cho CW; Choi JS; Yang KH; Shin SC
Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
[TBL] [Abstract][Full Text] [Related]
13. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.
Wu J; Shen Q; Fang L
Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of a bioadhesive film for transdermal delivery of propranolol hydrochloride.
Rasool BK; Aziz US; Sarheed O; Rasool AA
Acta Pharm; 2011 Sep; 61(3):271-82. PubMed ID: 21945906
[TBL] [Abstract][Full Text] [Related]
15. Characterization and therapeutic efficacy evaluation of glimepiride and L-arginine co-amorphous formulation prepared by supercritical antisolvent process: Influence of molar ratio and preparation methods.
Park H; Jin Seo H; Hong SH; Ha ES; Lee S; Kim JS; Baek IH; Kim MS; Hwang SJ
Int J Pharm; 2020 May; 581():119232. PubMed ID: 32240805
[TBL] [Abstract][Full Text] [Related]
16. [Preparation and evaluation in vivo and in vitro of glimepiride gel-matrix controlled-release patch].
Zhang Y; Xu DH; Ma Z; Chen Y; Zhao JJ; Xu SB
Yao Xue Xue Bao; 2004 Aug; 39(8):640-4. PubMed ID: 15563069
[TBL] [Abstract][Full Text] [Related]
17. Glimepiride-Loaded Nanoemulgel; Development, In Vitro Characterization, Ex Vivo Permeation and In Vivo Antidiabetic Evaluation.
Razzaq FA; Asif M; Asghar S; Iqbal MS; Khan IU; Khan SU; Irfan M; Syed HK; Khames A; Mahmood H; Ibrahim AY; El Sisi AM
Cells; 2021 Sep; 10(9):. PubMed ID: 34572054
[TBL] [Abstract][Full Text] [Related]
18. New in-situ gelling biopolymer-based matrix for bioavailability enhancement of glimepiride; in-vitro/in-vivo x-ray imaging and pharmacodynamic evaluations.
Awadeen RH; Boughdady MF; Meshali MM
Pharm Dev Technol; 2019 Jun; 24(5):539-549. PubMed ID: 30259768
[TBL] [Abstract][Full Text] [Related]
19. Glibenclamide Nanocrystals in a Biodegradable Chitosan Patch for Transdermal Delivery: Engineering, Formulation, and Evaluation.
Ali HSM; Hanafy AF
J Pharm Sci; 2017 Jan; 106(1):402-410. PubMed ID: 27866687
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of chitosan/hyaluronan film for transdermal delivery of thiocolchicoside.
Bigucci F; Abruzzo A; Saladini B; Gallucci MC; Cerchiara T; Luppi B
Carbohydr Polym; 2015 Oct; 130():32-40. PubMed ID: 26076598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
